Pharmacokinetics and pharmacodynamics of antibacterial peptide NZX in Staphylococcus aureus mastitis mouse model

被引:0
|
作者
Xueling Zheng
Na Yang
Ruoyu Mao
Ya Hao
Da Teng
Jianhua Wang
机构
[1] Chinese Academy of Agricultural Sciences,Gene Engineering Laboratory, Feed Research Institute
[2] Chinese Academy of Agricultural Sciences,Innovative Team of Antimicrobial Peptides and Alternatives to Antibiotics, Feed Research Institute
[3] Key Laboratory of Feed Biotechnology,undefined
[4] Ministry of Agriculture and Rural Affairs,undefined
来源
关键词
Antimicrobial peptide NZX; Mechanism of action; Pharmacokinetics; Pharmacodynamics; Mouse mastitis model;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Selenium suppresses inflammation by inducing microRNA-146a in Staphylococcus aureus-infected mouse mastitis model
    Sun, Weijing
    Wang, Qi
    Guo, Yingfang
    Zhao, Yifan
    Wang, Xinying
    Zhang, Zhenbiao
    Deng, Ganzhen
    Guo, Mengyao
    ONCOTARGET, 2017, 8 (67) : 110949 - 110964
  • [42] Mouse mastitis model of infection for antimicrobial compound efficacy studies against intracellular and extracellular forms of Staphylococcus aureus
    Brouillette, E
    Grondin, G
    Lefebvre, U
    Talbot, BG
    Malouin, F
    VETERINARY MICROBIOLOGY, 2004, 101 (04) : 253 - 262
  • [43] The pharmacodynamics of fosfomycin against Staphylococcus aureus studied in an in vitro model of infection
    Noel, Alan
    Attwood, Marie
    Bowker, Karen
    MacGowan, Alasdair
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (01)
  • [44] Pharmacokinetics and pharmacodynamics of gatifloxacin against Streptococcus pneumoniae and Staphylococcus aureus in a granulocyte-rich exudate
    Trampuz, A
    Laifer, G
    Wenk, M
    Rajacic, Z
    Zimmerli, W
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) : 3630 - 3633
  • [45] Pharmacokinetics and pharmacodynamics of levofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in human skin blister fluid
    Trampuz, A
    Wenk, M
    Rajacic, Z
    Zimmerli, W
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (05) : 1352 - 1355
  • [46] Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle
    Gill, J. J.
    Pacan, J. C.
    Carson, M. E.
    Leslie, K. E.
    Griffiths, M. W.
    Sabour, P. M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (09) : 2912 - 2918
  • [47] Screening of medicinal plants for antibacterial activities on Staphylococcus aureus strains isolated from bovine mastitis
    Diaz, Marisa A. N.
    Rossi, Ciro C.
    Mendonca, Vitor R.
    Silva, Danielle M.
    Ribon, Andrea de O. B.
    Aguilar, Ananda P.
    Munoz, Gaspar D.
    REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY, 2010, 20 (05): : 724 - 728
  • [48] Antibiofilm and antibacterial effects of specific chitosan molecules on Staphylococcus aureus isolates associated with bovine mastitis
    Asli, Abdelhamid
    Brouillette, Eric
    Ster, Celine
    Ghinet, Mariana Gabriela
    Brzezinski, Ryszard
    Lacasse, Pierre
    Jacques, Mario
    Malouin, Francois
    PLOS ONE, 2017, 12 (05):
  • [49] Pharmacokinetics/Pharmacodynamics of Peptide Deformylase Inhibitor GSK1322322 against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Rodent Models of Infection
    Hoover, Jennifer
    Lewandowski, Thomas
    Straub, Robert J.
    Novick, Steven J.
    DeMarsh, Peter
    Aubart, Kelly
    Rittenhouse, Stephen
    Zalacain, Magdalena
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) : 180 - 189
  • [50] Synthetic Cationic Lipopeptide Can Effectively Treat Mouse Mastitis Caused by Staphylococcus aureus
    Peng, Jie
    Lu, Qiangsheng
    Yuan, Lvfeng
    Zhang, Hecheng
    BIOMEDICINES, 2023, 11 (04)